Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 171
Titolo Data di pubblicazione Autore(i) File
Replication-defective Herpes Simplex virus vectors for gene transfer in vivo 1-gen-1996 Marconi, P; Krisky, D; Oligino, T; Poliani, Pietro Luigi; Ramakrishnan, R; Goins, Wf; Fink, Dj; Glorioso, Jc
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:VP16 1-gen-1996 Oligino, T; Poliani, Pietro Luigi; Marconi, P; Bender, Ma; Schmidt, Mc; Fink, Dj; Glorioso, Jc
Incorporation of nuclear matrix attachment elements into the Herpes Simplex virus type 1 genome does not induce long term expression of a foreign gene during latency. 1-gen-1996 Makarova, O; Gorneva, G; Wu, F; Villeponteau, B; Poliani, Pietro Luigi; Fink, Dj; Levine, M.
Detection of HSV-1 latency associated transcript expression in trigeminal ganglion by in situ reverse transcriptase PCR 1-gen-1996 Ramakrishnan, R; Poliani, Pietro Luigi; Levine, M; Glorioso, Jc; Fink, Dj
Herpes Simplex virus vectors for gene transfer to the nervous system 1-gen-1997 Goins, Wf; Krisky, D; Marconi, P; Oligino, T; Ramakrishnan, R; Poliani, Pietro Luigi; Fink, Dj; Glorioso, Jc
Development of an HSV-based vector for the treatment of Parkinson’s Disease 1-gen-1997 Fink, Dj; Poliani, Pietro Luigi; Oligino, T; Krisky, D; Goins, Wf; Glorioso, Jc
Engineering Herpes Simplex virus vectors for human gene therapy 1-gen-1997 Glorioso, Jc; Goins, Wf; Schmidt, Mc; Oligino, T; Krisky, D; Marconi, P; Cavalcoli, Jd; Ramakrishnan, R; Poliani, Pietro Luigi; Fink, Dj
Deletion of the S component inverted repeat sequence c’ and nonessential genes US1 through US5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system 1-gen-1997 Rasty, S; Poliani, Pietro Luigi; Fink, Dj; Glorioso, Jc
Drug inducible transgene expression in brain using a Herpes Simplex virus vector 1-gen-1998 Oligino, T; Poliani, Pietro Luigi; Wang, Y; Tsai, Sy; Omalley, Bw; Fink, Dj; Glorioso, Jc
A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokines 1-gen-1998 Martino, G; Furlan, R; Galbiati, F; Poliani, Pietro Luigi; Bergami, A; Grimaldi, Lme; Adorini, L; Comi, G.
Central nervous system delivery of interleukin-4 by a non-replicetive herpes simplex type 1 viral vector ameliorates autoimmune demyelination 1-gen-1998 Furlan, R; Poliani, Pietro Luigi; Galbiati, F; Bergami, A; Grimaldi, Lme; Comi, G; Adorini, L; Martino, G.
Peripheral levels of caspase-1 mRNA correlate with disease activity in multiple sclerosis patients 1-gen-1999 Furlan, R; Filippi, M; Bergami, A; Rocca, M; Martinelli, V; Poliani, Pietro Luigi; Grimaldi, Lme; Desina, G; Comi, G; Martino, G.
Caspase-1 regulates the inflammatory process leading to autoimmune demyelination 1-gen-1999 Furlan, R; Martino, G; Galbiati, F; Poliani, Pietro Luigi; Smiroldo, S; Bergami, A; Desina, G; Comi, G; Flavell, R; Su, M; Adorini, L.
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 1-gen-2000 Martino, G; Poliani, Pietro Luigi; Marconi, P; Furlan, R.
Cytokine Therapy in Immune-mediated Demyelinating Diseases of the Central Nervous System: a Novel Gene Therapy Approach 1-gen-2000 Martino, G; Poliani, Pietro Luigi; Furlan, R; Marconi, P; Glorioso, Jc; Adorini, L; Comi, G.
Cytokines and Immunity in Multiple Sclerosis: the Dual Signal Hypothesis 1-gen-2000 Martino, G; Furlan, R; Brambilla, E; Bergami, A; Ruffini, F; Gironi, M; Poliani, Pietro Luigi; Grimaldi, Lme; Comi, G.
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3 1-gen-2000 Mattner, F; Smiroldo, S; Galbiati, F; Muller, M; DI LUCIA, P; Poliani, Pietro Luigi; Martino, G; PANINA BORDIGNON, P; Adorini, L.
The pathogenic role of inflammation in multiple sclerosis 1-gen-2000 Martino, G; Furlan, R; Poliani, Pietro Luigi
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 1-gen-2001 Furlan, R; Poliani, Pietro Luigi; Marconi, P. C.; Bergami, A; Ruffini, F; Adorini, L; Glorioso, J. C.; Comi, G; Martino, G.
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 1-gen-2001 Ruffini, F; Furlan, R; Poliani, Pietro Luigi; Brambilla, E; Marconi, P; Bergami, A; Desina, G; Glorioso, Jc; Comi, G; Martino, G.
Mostrati risultati da 1 a 20 di 171
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile